Literature DB >> 17823091

Novel HIV treatment approved.

Heather M Groeschen.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17823091     DOI: 10.2146/news070079

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  4 in total

1.  Hepatotoxicity observed in clinical trials of aplaviroc (GW873140).

Authors:  W G Nichols; H M Steel; T Bonny; K Adkison; L Curtis; J Millard; K Kabeya; N Clumeck
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

2.  Activity of the small modified amino acid alpha-hydroxy glycineamide on in vitro and in vivo human immunodeficiency virus type 1 capsid assembly and infectivity.

Authors:  Samir Abdurahman; Akos Végvári; Masoud Youssefi; Michael Levi; Stefan Höglund; Elin Andersson; Peter Horal; Bo Svennerholm; Jan Balzarini; Anders Vahlne
Journal:  Antimicrob Agents Chemother       Date:  2008-07-21       Impact factor: 5.191

3.  Isolation and characterization of a small antiretroviral molecule affecting HIV-1 capsid morphology.

Authors:  Samir Abdurahman; Akos Végvári; Michael Levi; Stefan Höglund; Marita Högberg; Weimin Tong; Ivan Romero; Jan Balzarini; Anders Vahlne
Journal:  Retrovirology       Date:  2009-04-08       Impact factor: 4.602

4.  Combating HIV resistance - focus on darunavir.

Authors:  Cécile L Tremblay
Journal:  Ther Clin Risk Manag       Date:  2008-08       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.